Showing results (181-190 of 17,196) with videos related to

Sort By:
Pageof 1,720
Genes, Chromosomes & Cancer|April 1, 1997
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cellsV M Wasenius, A Jekunen, O Monni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour modelsX Lin, Q Zhang, J R Rice, et al.
Journal of the National Cancer Institute|August 1, 1980
Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemiaS B Howell, B Chu, J Mendelsohn, et al.
Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.
Biochemical Pharmacology|May 25, 1993
Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitroA P Jekunen, D R Shalinsky, D K Hom, et al.
The Journal of Clinical Investigation|July 1, 1993
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesR D Christen, A P Jekunen, J A Jones, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 1998
Prediction-based threading of the hMSH2 DNA mismatch repair proteinM M de las Alas, R A de Bruin, L Ten Eyck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cellsS Aebi, D Fink, R Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
In vitro antineoplastic activity of a novel lanthionine-containing peptideH Zheng, D Fink, H Li, et al.
British Journal of Cancer|March 31, 1999
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cellsA Nehmé, R Baskaran, S Nebel, et al.
Pageof 1,720